Weiss Multi-Strategy Advisers’s Amedisys AMED Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-23,443	Closed	-$2.46M	–	650
2022 Q2	$2.46M	Buy	23,443 +20,513	+700%	+$2.62M	0.07%	349
2022 Q1	$505K	Buy	+2,930	New	+$438K	0.01%	560
2021 Q3	–	Sell	-2,793	Closed	-$684K	–	667
2021 Q2	$684K	Buy	2,793 +99	+4%	+$26K	0.02%	533
2021 Q1	$713K	Sell	2,694 -110	-4%	-$31K	0.02%	520
2020 Q4	$822K	Sell	2,804 -201	-7%	-$51.5K	0.02%	509
2020 Q3	$710K	Buy	+3,005	New	+$683K	0.02%	454
2020 Q1	–	Sell	-10,000	Closed	-$1.67M	–	417
2019 Q4	$1.67M	Buy	+10,000	New	+$1.49M	0.03%	443

Other funds holding AMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Weiss Multi-Strategy Advisers's AMED Position: Q3 2022 in Review

Weiss Multi-Strategy Advisers sold out of Amedisys (AMED) in Q3 2022, closing a stake of 23,443 shares — an estimated $2.46M sold.

Weiss Multi-Strategy Advisers first reported a position in AMED in Q4 2019 and held it in 7 quarters. The position peaked at $2.46M in Q2 2022. 286 funds tracked by Wall St. Rank hold AMED as of Q3 2022.

Weiss Multi-Strategy Advisers reported no remaining Amedisys position as of Q3 2022 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 23,443 Amedisys shares in Q3 2022, an estimated $2.46M.
Weiss Multi-Strategy Advisers first reported a position in Amedisys in Q4 2019 and held it in 7 quarters.
Weiss Multi-Strategy Advisers's Amedisys position peaked at $2.46M in Q2 2022.
286 funds tracked by Wall St. Rank held Amedisys as of Q3 2022.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q3 2022, filed 14 Nov 2022.